Stay updated on PAAP for Pralsetinib in NSCLC and MTC Clinical Trial
Sign up to get notified when there's something new on the PAAP for Pralsetinib in NSCLC and MTC Clinical Trial page.

Latest updates to the PAAP for Pralsetinib in NSCLC and MTC Clinical Trial page
- Check3 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a newer version of the page for tracking purposes.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page shows a revision tag updated from v3.6.3 to v3.6.4, indicating a new patch or update to the page or underlying system. This is a minor update and does not change the displayed study details or user-facing content.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating a routine deployment update rather than a change to the study content.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, replacing the previous build indicator with a newer minor platform update.SummaryDifference0.1%

- Check62 days agoChange DetectedNew Help/Information sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention/Treatment label has been standardized, and the previous 'Intervention / Treatment' label and the 'Revision: v3.5.5' note were removed.SummaryDifference0.6%

- Check69 days agoChange DetectedThe page revision tag updated from v3.5.4 to v3.5.5. This appears to be a minor software update and does not change the study content.SummaryDifference0.1%

Stay in the know with updates to PAAP for Pralsetinib in NSCLC and MTC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PAAP for Pralsetinib in NSCLC and MTC Clinical Trial page.